Seeing Is Believing
Healthcare - Sector
Acasti Pharma's activity chart (see below) currently has 12 price targets and 14 ratings on display.
Analysts average stock forecasts to be materialized ratio is 22.92% with an average time for these price targets to be met of 20.88 days.
Most recent stock forecast was given by OREN LIVNAT from HC WAINWRIGHT on 26-Sep-2024. First documented stock forecast 09-Jul-2019.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 12-Jul-2023
$12
$8.63 (256.08%)
$12
2 years 2 days ago
(26-Sep-2024)
0/2 (0%)
$8.93 (290.88%)
Buy Since 26-Sep-2024
$8
$4.63 (137.39%)
2 years 2 days ago
(26-Sep-2024)
0/1 (0%)
$4.93 (160.59%)
Buy
$2.5
$-0.28 (-10.07%)
3 years 7 months 13 days ago
(15-Feb-2023)
1/1 (100%)
$1.86 (290.63%)
145
Buy Since 18-Jul-2019
$29.41
$26.04 (772.70%)
$29.41
4 years 3 months 6 days ago
(22-Jun-2022)
0/5 (0%)
$24 (443.62%)
Buy Since 09-Jul-2019
$12
$8.63 (256.08%)
$150
6 years 26 days ago
(02-Sep-2020)
1/2 (50%)
$1.58 (15.16%)
19
What is ACST (Acasti Pharma) average time for price targets to be met?
Which analyst most recently updated their price target on ACST (Acasti Pharma)?
Which analyst has the current lower performing score on ACST (Acasti Pharma) with a proven track record?
Which analyst has the most public recommendations on ACST (Acasti Pharma)?
Which analyst is the currently most bullish on ACST (Acasti Pharma)?
Which analyst is the currently most reserved on ACST (Acasti Pharma)?